Hot Products

Gomisin E
Catalog No: CFN96725

Gomisin E is a natural product from Schizandra chinensis.

Gomisin F
Catalog No: CFN92719

Standard reference

Gomisin G
Catalog No: CFN90123

Gomisin G is a drug candidate for treatment of cardiovascular disease, and it is a good substrate of CYP2C9, and can be easily affected by the inhibitors of CYP2C9. Gomisin G exhibits anti-tumor activities, it exhibits potent anti-HIV activity with EC50 and therapeutic index (TI) values of 0.006 microgram/mL and 300, respectively.

Gomisin H
Catalog No: CFN94008

Gomisin H is a natural product from Schizandra chinensis.

Gomisin J
Catalog No: CFN90124

Gomisin J is a good substrate of cytochrome P450 3A4(CYP3A4), it has vasodilatory, anti-inflammatory, anti-diabetes, anti-oxidant, and anti-cancer effects, it also has preventive effects on angiotensin II-induced hypertension via an increased nitric oxide bioavailability. Gomisin J has potential benefits in treating nonalcoholic fatty liver disease, it can suppress lipid accumulation by regulating the expression of lipogenic and lipolytic enzymes and inflammatory molecule. Halogenated gomisin J is a potent inhibitor of the cytopathic effects of human immunodeficiency virus type 1 (HIV-1) on MT-4 human T cells (50% effective dose, 0.1 to 0.5 microM).

Gomisin K1
Catalog No: CFN96724

Gomisin K1 is a natural product from Schizandra chinensis BAILL.

Gomisin L1
Catalog No: CFN96734

(-)-Gomisin L1 induces G2/M arrest and apoptosis in human ovarian cancer cells.

Gomisin L2
Catalog No: CFN96726

Gomisin L2 is a natural product from Schizandra chinensis BAILL.

Gomisin M2
Catalog No: CFN97306

Gomisin M2 is an anti-HIV agent.

Gomisin N
Catalog No: CFN90125

Gomisin N has anti-oxdiant, anti-inflammatory, anti-cancer and anti-hepatitis activities; it produces beneficial sedative and hypnotic bioactivity, which may be mediated by the modification of the serotonergic and GABAergic system. Gomisin N can enhance TNF-α-induced apoptosis by suppressing of NF-κB and EGFR signaling pathways, and potentiate TRAIL-induced apoptosis through ROS-mediated up-regulation of death receptors 4 and 5.